| Name | Title | Contact Details |
|---|
Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders. Through its medical solutions, Braxia aims to reduce the illness burden of brain-based disorders, such as major depressive disorder among others. Braxia is primarily focused on (i) owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. Braxia seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. Through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., Braxia currently operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Kitchener-Waterloo, Ottawa, and Montreal.
Affymetrix/USB Corporation is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Innov-X Systems Inc. is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Elements Behavioral Health is a Cerritos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Victorian Department of Health & Human Services develops and delivers policies, programs and services that support and enhance the wellbeing of all Victorians.